NVDA
54
2
ED
53
-2
KIM
77
-3
WYNN
42
4
KEY
41
-2
PNC
65
-2
PFE
28
2
SCHW
65
-2
AVGO
22
4
TXN
45
2
LMT
32
2
MRK
35
-5
PRGO
40
-3
KLAC
57
4
SO
62
-2
RIG
61
6
AAP
21
-21
HES
65
2
CHRW
42
-12
FSLR
50
4
NVDA
54
2
ED
53
-2
KIM
77
-3
WYNN
42
4
KEY
41
-2
PNC
65
-2
PFE
28
2
SCHW
65
-2
AVGO
22
4
TXN
45
2
LMT
32
2
MRK
35
-5
PRGO
40
-3
KLAC
57
4
SO
62
-2
RIG
61
6
AAP
21
-21
HES
65
2
CHRW
42
-12
FSLR
50
4
Financhill
Back

Ameriprise Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
69

AMP
Ameriprise Financial

Last Price:
573.82
Seasonality Move:
6.45%
Buy
58

SRPT
Sarepta Therapeutics

Last Price:
133.49
Seasonality Move:
14.88%
Buy
69
Ameriprise Financial (AMP) is a Buy

Is Ameriprise Financial a Buy, Sell or Hold?

  • The current Ameriprise Financial [AMP] share price is $573.97. The Score for AMP is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • AMP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

AMP Stock Price Chart

What is Ameriprise Financial's stock price today?

  • The Ameriprise Financial share price today is $573.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMP is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $133.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

AMP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.79 Buy
Relative Strength Index (14 RSI): 70.52 Buy
Chaikin Money Flow: -149245 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (521.48 - 573.22) Buy
Bollinger Bands (100): (420.63 - 526.55) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 63.54 Buy
Chaikin Money Flow: -725343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.81) Buy
Bollinger Bands (100): (119.21 - 141.67) Buy

AMP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 569.54 Buy
20-day SMA: 556.27 Buy
50-day SMA: 517.94 Buy
200-day SMA: 448.6 Buy
8-day EMA: 569.42 Buy
20-day EMA: 555.79 Buy
50-day EMA: 523.47 Buy
200-day EMA: 454.5 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.83 Buy
20-day SMA: 118.14 Buy
50-day SMA: 122.33 Buy
200-day SMA: 130.09 Buy
8-day EMA: 123.82 Buy
20-day EMA: 120.48 Buy
50-day EMA: 122.96 Buy
200-day EMA: 126.17 Buy

Ameriprise Financial Earnings Growth & AMP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.73 per share, and an increase next year of $3.84 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Ameriprise Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):